• 1
    Ellis WJ, Chetner MP, Preston SD, Brawer MK. Diagnosis of prostatic carcinoma: The yield of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography. J Urol 1994; 152: 4043
  • 2
    Keetch DW, Catalona WJ, Smith DS. Serial prostate biopsies in men with persistently elevated prostate specific antigen values. J Urol 1994; 151: 1571
  • 3
    Eskew LA, Bare RL, McCullough DL. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 1997; 157: 199
  • 4
    Ellis WJ & Brawer MK. The significance of isoechoic prostate carcinoma. J Urol 1994; 152: 23047
  • 5
    Hopper DH, Abendroth CS, Sturtz KW, Matthews YL, Hartzel JS, Potok PS. CT percutaneous biopsy guns. A comparison of end-cut and side-notch devices in cadaveric specimens. Am J Roentgenol 1995; 164: 1959
  • 6
    Bostwick DG. Evaluating prostate needle biopsy. Therapeutic and prognostic importance. CA Cancer J Clin 1997; 47: 297319
  • 7
    Norberg M, Bush C, Stavinoha J, Scarding PT, Magnusson A. Transrectal ultrasound guided core biopsy of the prostate – a comparison between the standard 1.2 mm needle and three thinner needles. Acta Radiol 1994; 35: 4637
  • 8
    Rodriguez LV & Terris MK. Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of the literature: J Urol 1998; 160: 211520
  • 9
    Naughton CK, Ornstein DK, Smith DS, Catalona WJ. Pain and morbidity of transrectal ultrasound guided prostate biopsy: a prospective randomised trial of 6 versus 12 cores. J Urol 2000; 163: 16871
  • 10
    Horninger W, Reissigl A, Fink K et al. Results of a prospective randomised study comparing the prostatic cancer detection rates in PSA screening volunteers undergoing 10 vs. 14 transrectal ultrasound guided biopsies. J Urol 1998; 159 (Suppl.): 180, A690